fullerene c60 has been researched along with Osteoarthritis of Knee in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kato, T; Masuko, K; Matsubayashi, K; Murayama, H; Nakamura, H; Nishioka, K; Shishido, K; Takada, H; Yano, M; Yudoh, K | 1 |
1 other study(ies) available for fullerene c60 and Osteoarthritis of Knee
Article | Year |
---|---|
Water-soluble C60 fullerene prevents degeneration of articular cartilage in osteoarthritis via down-regulation of chondrocyte catabolic activity and inhibition of cartilage degeneration during disease development.
Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Animals; Apoptosis; Cartilage, Articular; Cells, Cultured; Cellular Senescence; Chondrocytes; Disease Models, Animal; Disease Progression; Down-Regulation; Free Radical Scavengers; Fullerenes; Humans; Hyaluronic Acid; In Vitro Techniques; Osteoarthritis, Knee; Oxidative Stress; Rabbits | 2007 |